Interleukin-6 induces drug resistance in renal cell carcinoma

Metastatic renal cell carcinoma (mRCC) is a tumor entity with poor prognosis due to limited therapy options. Tyrosine kinase inhibitors (TKIs), the novel targeted agents have been used for the treatment of mRCC and have shown efficacy. Interferon (IFN)-α is also one of the most frequently used agent...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Fukushima J Med Sci
Huvudupphovsmän: Ishibashi, Kei, Koguchi, Tomoyuki, Matsuoka, Kanako, Onagi, Akifumi, Tanji, Ryo, Takinami-Honda, Ruriko, Hoshi, Seiji, Onoda, Mitsutaka, Kurimura, Yoshimasa, Hata, Junya, Sato, Yuichi, Kataoka, Masao, Ogawsa, Soichiro, Haga, Nobuhiro, Kojima, Yoshiyuki
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Fukushima Society of Medical Science 2018
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6305783/
https://ncbi.nlm.nih.gov/pubmed/30369518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5387/fms.2018-15
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk